...
机译:推荐剂量的idarucizumab可能并不总是足以持续逆转Dabigatran
Department of Emergency MedicineMedical University of ViennaVienna Austria;
Department of Emergency MedicineMedical University of ViennaVienna Austria;
Medical University of ViennaClinical Division of Hematology and HemostaseologyVienna Austria;
Department of Nephrology and DialysisMedical University of ViennaVienna Austria;
Department of AnesthesiologyDuke UniversityDurham NC USA;
Department of Emergency MedicineMedical University of ViennaVienna Austria;
antidote; bleeding; dabigatran; dialysis; idarucizumab;
机译:推荐剂量的idarucizumab可能并不总是足以持续逆转Dabigatran
机译:推荐剂量的idarucizumab可能并不总是足以持续逆转Dabigatran
机译:推荐剂量的idarucizumab可能并不总是足以进行Dabigatran的持续逆转:评论
机译:Dabigatran逆转的PK / PD模型在非临床研究中的非临床研究和人类反应预测
机译:“需求推荐器”:在可持续软件项目的需求工程中使用多个标准推荐器系统的拟议框架
机译:在多创伤患者中含有idaarcizumab的Dabigatran难度逆转:剂量问题?
机译:推荐剂量的idarucizumab可能并不总是足以达到Dabigatran的持续逆转:评论